Novartis sells Red Line HealthCare for $230 million
This article was originally published in Clinica
Executive Summary
Life sciences company Novartis is to sell its US medical supplies distributor, Red Line HealthCare, to healthcare supply management company McKesson for around $230 million in cash and assumed debt. All of Red Line's staff will be taken on by McKesson.